William Hoffman, Director at Inari Medical, Inc. (NARI), sold 106,750 shares at $50.09 ($5.5M) on 2024-11-18, disclosed to the SEC on 2024-11-20.
Scheduled sale ($5.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.09 | 3,000 | $150K | 2.7% |
| 2 | $50.64 | 10,250 | $519K | 9.5% |
| 3 | $51.16 | 9,750 | $499K | 9.1% |
| 4 | $51.16 | 9,750 | $499K | 9.1% |
| 5 | $51.32 | 33,784 | $1.7M | 31.7% |
| 6 | $51.32 | 33,784 |
| $1.7M |
| 31.7% |
| 7 | $52.11 | 3,216 | $168K | 3.1% |
| 8 | $52.11 | 3,216 | $168K | 3.1% |
| Total | $51.24 avg | 106,750 | $5.5M | 100% |
| Filing → |
| NARI | SELL | 2024-10-31 | $2.0M | — | Filing → |
| NARI | SELL | 2024-10-18 | $3.6M | — | Filing → |
| NARI | SELL | 2024-09-18 | $3.7M | — | Filing → |